Abstract
Docking studies of arilloxazines family compounds and chloroquine will be done to act as inhibitors of the Plasmodium falciparum Glutathione Reductase, Dihydrofolate Reductase-Thymidylate Synthase and Lactate Dehydrogenase enzymes, related with malaria. Also it will be analyzed, through docking studies, the interaction of the same inhibitors with the human Glutathione Reductase, for compa…